Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 6 | 2024 | 291 | 2.190 |
Why?
|
| TRPP Cation Channels | 1 | 2024 | 2 | 0.960 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2024 | 9 | 0.950 |
Why?
|
| Complement C3 | 1 | 2024 | 20 | 0.950 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2024 | 5 | 0.950 |
Why?
|
| Sepsis | 4 | 2013 | 226 | 0.830 |
Why?
|
| Diabetic Nephropathies | 1 | 2022 | 61 | 0.810 |
Why?
|
| Kidney | 4 | 2022 | 677 | 0.770 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2024 | 303 | 0.750 |
Why?
|
| Stilbenes | 2 | 2011 | 54 | 0.710 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 281 | 0.650 |
Why?
|
| Renal Circulation | 3 | 2013 | 59 | 0.550 |
Why?
|
| Microcirculation | 3 | 2013 | 72 | 0.510 |
Why?
|
| Free Radical Scavengers | 2 | 2011 | 25 | 0.450 |
Why?
|
| Rolipram | 1 | 2013 | 2 | 0.450 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2013 | 4 | 0.450 |
Why?
|
| Epithelial Cells | 3 | 2011 | 210 | 0.390 |
Why?
|
| Peroxynitrous Acid | 1 | 2010 | 33 | 0.350 |
Why?
|
| Antioxidants | 1 | 2011 | 237 | 0.330 |
Why?
|
| Prognosis | 2 | 2024 | 1963 | 0.320 |
Why?
|
| Mice | 6 | 2024 | 5673 | 0.280 |
Why?
|
| Pedigree | 1 | 2024 | 125 | 0.230 |
Why?
|
| Glomerular Filtration Rate | 3 | 2013 | 111 | 0.230 |
Why?
|
| Renal Replacement Therapy | 1 | 2023 | 28 | 0.220 |
Why?
|
| Mutation | 2 | 2024 | 1288 | 0.220 |
Why?
|
| Reactive Nitrogen Species | 3 | 2011 | 23 | 0.210 |
Why?
|
| Animals | 7 | 2024 | 13141 | 0.210 |
Why?
|
| Male | 6 | 2024 | 25572 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 4 | 2013 | 1782 | 0.170 |
Why?
|
| Rats | 2 | 2024 | 3277 | 0.170 |
Why?
|
| Middle Aged | 2 | 2024 | 12356 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2022 | 563 | 0.160 |
Why?
|
| Kidney Tubules | 2 | 2011 | 61 | 0.160 |
Why?
|
| Humans | 4 | 2024 | 50201 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2024 | 1027 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 1419 | 0.140 |
Why?
|
| Blood Flow Velocity | 2 | 2013 | 100 | 0.130 |
Why?
|
| Blood Pressure | 3 | 2011 | 527 | 0.120 |
Why?
|
| Female | 2 | 2024 | 26829 | 0.110 |
Why?
|
| Heart Rate | 2 | 2011 | 301 | 0.110 |
Why?
|
| Metalloporphyrins | 1 | 2011 | 6 | 0.100 |
Why?
|
| Cellular Microenvironment | 1 | 2011 | 27 | 0.100 |
Why?
|
| Epithelium | 1 | 2011 | 65 | 0.100 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2011 | 17 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2011 | 37 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 98 | 0.090 |
Why?
|
| Aged | 1 | 2024 | 9505 | 0.090 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2010 | 9 | 0.090 |
Why?
|
| Molsidomine | 1 | 2010 | 5 | 0.090 |
Why?
|
| Serum Albumin, Bovine | 1 | 2010 | 22 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 177 | 0.090 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 142 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2011 | 670 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2011 | 264 | 0.080 |
Why?
|
| Histones | 1 | 2011 | 296 | 0.080 |
Why?
|
| Cell Survival | 1 | 2010 | 590 | 0.080 |
Why?
|
| Cell Line | 1 | 2010 | 1010 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2011 | 763 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 196 | 0.060 |
Why?
|
| Time Factors | 1 | 2011 | 2909 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2006 | 212 | 0.060 |
Why?
|
| Ligation | 2 | 2011 | 62 | 0.050 |
Why?
|
| Capillary Permeability | 2 | 2011 | 35 | 0.050 |
Why?
|
| Nitrites | 2 | 2011 | 32 | 0.040 |
Why?
|
| Nitrates | 2 | 2011 | 30 | 0.040 |
Why?
|
| Capillaries | 2 | 2011 | 50 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 973 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 82 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 113 | 0.020 |
Why?
|
| Telemetry | 1 | 2011 | 29 | 0.020 |
Why?
|
| Peritonitis | 1 | 2011 | 27 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2011 | 47 | 0.020 |
Why?
|
| Cecum | 1 | 2011 | 59 | 0.020 |
Why?
|
| Hypothermia | 1 | 2011 | 34 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2011 | 75 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 249 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 317 | 0.020 |
Why?
|
| Chromatin | 1 | 2011 | 138 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 367 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 369 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 579 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 406 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 655 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 732 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 1581 | 0.020 |
Why?
|
| NADP | 1 | 2006 | 22 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2006 | 13 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2006 | 40 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 64 | 0.020 |
Why?
|
| Creatinine | 1 | 2006 | 142 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 108 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2006 | 174 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 587 | 0.020 |
Why?
|